147. Diagnosis of catheter-related infections / F. Blot [et al.] //
Catheter related infections. 2-nd ed. New York. - 2004. - P. 37-72.
148. Drug Actions, Interactions, Reactions. Program of the American
Academy of Dermatology / N.H. Shear [et al.] // Academy, 2000, 5.
149. Edwards, I.R. Adverse drug reactions: definitions, diagnosis, and
management / I.R.Edwards, J.K.Aronson // The Lancet. - 2000. - Vol 356 . -
N7: 1255-1261.
150. Epidemiology of drug exposure and adverse drug reactions in two
swiss departments of internal medicine / K. Fattinger [et al.] // Br. J. Clin.
Pharmacol., 2000, 49(2), 158-167.
151. Epidemiology of drug exposure and adverse drug reactions in two
swiss departments of internal medicine / K. Fattinger [et al.] // Br. J. Clin.
Pharmacol., 2000, 49(2), 158-167.
152. Fletcher, A.P. Spontaneous adverse drug reaction reporting vs.
event reporting vs. event monitoring: a comparison / A.P. Fletcher // J. Roy.
Soc. Med., 1991, 84, 341-344.
153. Gualeri,
E.
Катетеризация
подключичной
вены:
ультразвуковой контроль позволяет менее опытным врачам добиться
лучших результатов / E. Gualeri, S.A. Deppe, M.E. Sipperly // Вестник
интенсивной терапии, 2006. - №4. - С. 77-81.
154. Haig, K. One Hospital’s Journey Toward Patient Safety,
Medscape Money & Medicine, 2003, 4(2).
155. Immunological principles of adverse drug reactions: the initiation
and propagation of immune responses elicited by drug treatment / D.J. Naisbitt
[et al.] // Drug. Saf. 2000, 23(6), 483-507.
156. Incidence of adverse drug events and potential adverse drug
events. Implications for prevention / D.W. Bates [et al.] // JAMA, 1995, 274,
29-34.
157. Incidence of adverse drug events and potential adverse drug
194